Prime MedTech

{
  "notary": {
    "name": "Paul Wellens",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Mortsel",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-07-05",
    "filing_date": "2024-07-03",
    "act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), WIJZIGING RECHTSVORM, ONTSLAGEN, BENOEMINGEN"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-06-27",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "full_restatement",
      "legal_form_change"
    ],
    "scope": "full_restatement",
    "trigger": "wvv_adaptation",
    "language_after": "nl",
    "language_before": "nl"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0722.963.566",
    "name_full_after": "Prime MedTech",
    "legal_form_after": "BV",
    "name_full_before": "Prime MedTech",
    "current_zetel_raw": "Kwikstaartlaan 11, 2610 Antwerpen",
    "legal_form_before": "BVBA"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "Het werkelijk gestort kapitaal en de wettelijke reserve worden van rechtswege omgezet in een statutair onbeschikbare eigen vermogensrekening.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "39,\u00A72,tweede lid"
    },
    {
      "summary": "Alle aandelen van de vennootschap zijn verenigd in \u00E9\u00E9n hand.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "2:8, \u00A74"
    }
  ],
  "governance_change": {
    "organ_kind_after": "monistic",
    "organ_kind_before": "collegial",
    "admin_delegated_added": [],
    "representation_rule_after": "enige_bestuurder",
    "co_signature_threshold_eur": null,
    "representation_rule_before": "twee_gezamenlijk"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Paul Wellens",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "Afschrift van het proces-verbaal"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": "De vennootschap heeft tot voorwerp het verzorgen van market development, commerci\u00EBle en market access consulting voor healthcare bedrijven die een activiteit in Europa (en OUS) wensen op te starten of uit te breiden, inclusief optreden als invoerder en verdeler voor medical device, biotech of farmaceutische bedrijven.",
  "capital_structure_change": {
    "operations": [
      "wvv_capital_release"
    ],
    "split_ratio": null,
    "shares_after": 100,
    "shares_before": 100,
    "capital_after_eur": 97000.0,
    "capital_before_eur": 18600.0,
    "share_classes_after": [
      {
        "count": 100,
        "label": "aandeel",
        "rights_summary": "gelijk recht in de winstverdeling en in het vereffeningssaldo",
        "voting_per_share": 1.0
      }
    ]
  },
  "coordinated_text_lineage": null
}